Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses

Infusion of human third-party mesenchymal stromal cells (MSCs) appears to be a promising therapy for acute graft-versus-host disease (aGvHD). To date, little is known about how MSCs interact with the body's innate immune system after clinical infusion. This study shows, that exposure of MSCs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Guido, Jitschin, Regina, von Bahr, Lena, Rasmusson-Duprez, Ida, Sundberg, Berit, Lönnies, Lena, Elgue, Graciela, Nilsson-Ekdahl, Kristina, Mougiakakos, Dimitrios, Lambris, John D., Ringdén, Olle, Le Blanc, Katarina, Nilsson, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128611/
https://www.ncbi.nlm.nih.gov/pubmed/21747949
http://dx.doi.org/10.1371/journal.pone.0021703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128611/
https://www.ncbi.nlm.nih.gov/pubmed/21747949
http://dx.doi.org/10.1371/journal.pone.0021703

Ejemplares similares